Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities

scientific article

Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1024460J
P356DOI10.1371/JOURNAL.PONE.0124460
P932PMC publication ID4404139
P698PubMed publication ID25893988
P5875ResearchGate publication ID276087380

P2093author name stringOla Forslund
Hanna Johansson
Lotten Darlin
Kaj Bjelkenkrantz
Joakim Dilllner
P2860cites workNucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.Q50734604
Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.Q54277497
A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial LesionQ58475803
Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesionsQ74310418
Screening history of women in Malmö with invasive cervical cancerQ79516632
Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)Q84967041
Epidemiologic classification of human papillomavirus types associated with cervical cancerQ29616213
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideQ29617514
Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus testQ33951517
Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasiaQ33978458
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus typesQ34362772
Bead-based multiplex genotyping of human papillomavirusesQ34430808
PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomavirusesQ34611368
Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based studyQ35108590
Molecular biology of human papillomavirus infection and cervical cancerQ36441612
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samplesQ36948137
Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirusQ37116753
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countriesQ37291430
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rateQ37294687
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.Q37503427
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancerQ38064070
Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesionQ38408998
Nucleotide sequence and phylogenetic classification of human papillomavirus type 67.Q42688382
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceQ44677030
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)e0124460
P577publication date2015-04-20
P1433published inPLOS OneQ564954
P1476titlePresence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities
P478volume10

Reverse relations

cites work (P2860)
Q49716711A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
Q26776336A review of the clinical performance of the Aptima HPV assay
Q91688493Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis
Q40228937Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease
Q47216037Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Q89666353HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
Q33597665Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis
Q91706741Population-based primary HPV mRNA cervical screening compared with cytology screening
Q54269409Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
Q64328556The Prevalence of Genus Alpha Human Papillomavirus in Women with Uterine Cervical Infection and/or Inflammation in Western Iran

Search more.